Report
Debbie Wang
EUR 100.00 For Business Accounts Only

ConvaTec is struggling to overcome operational problems, but its narrow moat is intact.

We're putting ConvaTec under review and plan to moderately lower our fair value estimate following CEO Paul Moraviec’s resignation and changes in inventory management at Medtronic--ConvaTec’s largest customer for infusion sets--that will materially lower infusion set sales in the fourth quarter. ConvaTec’s progress since its initial public offering could be characterized as one step forward, two steps back, in our opinion. Overall, we expect to further dial down our already-tempered projections ...
Underlying
ConvaTec Group Plc

ConvaTec Group is a holding company. Through its subsidiaries, Co. is a global medical products and technologies group. Co. has four franchises: Advanced Wound Care, which provides wound dressings, devices and skin care products used for the management of acute and chronic wounds; Ostomy Care, which focuses on devices, accessories and services for individuals who have a stoma; Continence and Critical Care, which provides products for people with urinary continence issues; and Infusion Devices, which develops and manufactures disposable infusion sets for the suppliers of insulin pumps for diabetes treatment and similar pumps used in continuous infusion treatments for other conditions.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Debbie Wang

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch